Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting

被引：0
|
作者：
Michael Scott Kook
Susan Simonyi
Yong Ho Sohn
Chan Yun Kim
Ki Ho Park
机构：
[1] Asan Medical Centre,Department of Ophthalmology
[2] Allergan Singapore Pte,Department of Ophthalmology
[3] Ltd.,Department of Ophthalmology
[4] Mapletree Business City,undefined
[5] Kim’s Eye Hospital,undefined
[6] Yonsei University,undefined
[7] College of Medicine,undefined
[8] Seoul National University Hospital,undefined
来源：
Japanese Journal of Ophthalmology | 2015年 / 59卷
关键词：
Bimatoprost; Glaucoma; Hyperemia; Ocular hypertension; Prostamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：325 / 334
页数：9
相关论文
共 50 条
  • [1] Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting
    Kook, Michael Scott
    Simonyi, Susan
    Sohn, Yong Ho
    Kim, Chan Yun
    Park, Ki Ho
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2015, 59 (05) : 325 - 334
  • [2] Bimatoprost 0.01% in treatment-naive patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
    Park, Ki Ho
    Simonyi, Susan
    Kim, Chan Yun
    Sohn, Yong Ho
    Kook, Michael Scott
    BMC OPHTHALMOLOGY, 2014, 14
  • [3] Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
    Ki Ho Park
    Susan Simonyi
    Chan Yun Kim
    Yong Ho Sohn
    Michael Scott Kook
    BMC Ophthalmology, 14
  • [4] Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension
    Cengiz Akarsu
    Sevda Yılmaz
    Pelin Taner
    Ahmet Ergin
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2004, 242 : 814 - 818
  • [5] Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension
    Akarsu, C
    Yilmaz, S
    Taner, P
    Ergin, A
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 242 (10) : 814 - 818
  • [6] Bimatoprost and Bimatoprost/Timolol Fixed Combination in Patients with Open-Angle Glaucoma and Ocular Hypertension
    Katsanos, Andreas
    Dastiridou, Anna I.
    Fanariotis, Michael
    Kotoula, Maria
    Tsironi, Evangelia E.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (01) : 67 - 71
  • [7] Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
    Pfennigsdorf, Stefan
    Ramez, Osman
    von Kistowski, Gerrit
    Maeder, Birgit
    Eschstruth, Peter
    Froboese, Michael
    Thelen, Ulrich
    Spraul, Christoph
    Schnober, Dietmar
    Cooper, Hazel
    Laube, Thomas
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 739 - 746
  • [8] Bimatoprost A Review of its Use in Open-Angle Glaucoma and Ocular Hypertension
    Curran, Monique P.
    DRUGS & AGING, 2009, 26 (12) : 1049 - 1071
  • [9] Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
    Pillunat, Lutz E.
    Eschstruth, Peter
    Haesemeyer, Stefan
    Thelen, Ulrich
    Foja, Christian
    Leaback, Richard
    Pfennigsdorf, Stefan
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 1759 - 1765
  • [10] Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study
    Chen, Ying Ying
    Wang, Tsing-Hong
    Liu, Catherine
    Wu, Kwou-Yeung
    Chiu, Shin-Lin
    Simonyi, Susan
    Lu, Da-Wen
    BMC OPHTHALMOLOGY, 2016, 16
12345